Your provider can help you switch to Ozempic, Wegovy, or another appropriate medication while managing the transition to avoid disrupting your treatment
Impact of hepatitis B virus infection, non-alcoholic fatty liver disease, and hepatitis C virus co-infection on liver-related death among people tested for hepatitis B virus in British Columbia: results from a large longitudinal population-based cohort study
GABA and glutamate in migraine
By staying below the smallest available commercial dose and extending dosing intervals to 10, 14, 21, or 28 days, providers can deliver meaningful metabolic benefit with dramatically better tolerability and adherence
Since human studies are limited, long-term safety is still being evaluated